{"symbol": "ORPN", "companyName": "Bioblast Pharma Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "https://bioblastpharma.com", "description": "Bioblast Pharma Ltd is a clinical stage biotechnology company. It is engaged in the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.", "CEO": "Fredric D. Price", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}